A small molecule cocktail breaks the bottleneck of human primary hepatocytes culture
基本信息来源于合作网站,原文需代理用户跳转至来源网站获取
摘要:
It is estimated that more than 300 million people in China are suffering from different liver diseases including viral hepatitis,fatty liver,alcoholic liver,liver fibrosis,cirrhosis and liver cancer,of which about 400,000 people die each year [1].